PureTech Health plc (LON:PRTC – Get Free Report) shares crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 155.86 ($2.04) and traded as high as GBX 156 ($2.04). PureTech Health shares last traded at GBX 153 ($2.00), with a volume of 495,999 shares trading hands.
PureTech Health Stock Up 0.1 %
The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 47.27. The company has a market capitalization of £366.79 million, a PE ratio of -665.22 and a beta of 1.02. The company’s 50 day moving average is GBX 155.86 and its two-hundred day moving average is GBX 187.94.
About PureTech Health
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Further Reading
- Five stocks we like better than PureTech Health
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- What is the S&P 500 and How It is Distinct from Other Indexes
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Most Volatile Stocks, What Investors Need to Know
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
